Skip to main content
NIH funding notice PAR-14-293

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UH2/UH3)

Closed on March 9, 2017.

Posted
July 22, 2014
Close date
March 9, 2017
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,660,175 in first-year total cost, median $634,742.

Most frequent study sections

  1. Special Emphasis Panel[ZNS1 SRB-T (01)]2
  2. Special Emphasis Panel[ZNS1 SRB-T (03)]1
  3. Special Emphasis Panel[ZNS1 SRB-T (07)]1
  4. Special Emphasis Panel[ZNS1 SRB-T (14)]1
  5. Special Emphasis Panel[ZNS1 SRB-T (22)]1

Most frequent institutions

  1. AGENEBIO, INC.1
  2. EICOSIS, LLC1
  3. SCRIPPS FLORIDA1
  4. SCRIPPS RESEARCH INSTITUTE, THE1
  5. UNIVERSITY OF MICHIGAN AT ANN ARBOR1
Competing awards under PAR-14-293 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017Discovery/Development of GABA-A α5 Positive Allosteric Modulators for Treatment of MCI due to AD1UH2NS101856-01ROSENZWEIG-LIPSON, SHARONAGENEBIO, INC., MD$651,428ZNS1
2016Developing nonmuscle II inhibitors for substance use relapse1UH2NS096833-01GRIFFIN, PATRICK ROBERTKAMENECKA, THEODORE MMILLER, COURTNEY ASCRIPPS FLORIDA, FL$638,362ZNS1
2016Development of an Oral Analgesic for Neuropathic Pain1UH2NS094258-01BUCKPITT, ALAN RHAMMOCK, BRUCE DEICOSIS, LLC, CA$224,163ZNS1
2016Development of VU0652957 for the treatment of Parkinson's disease (PD)1UH2NS099066-01NISWENDER, COLLEEN MVANDERBILT UNIVERSITY, TN$124,768ZNS1
2015Discovery of non-addictive KOR antagonists for migraine prophylaxis1UH2NS093030-01ROBERTS, EDWARDSCRIPPS RESEARCH INSTITUTE, THE, CA$1,390,332ZNS1
2015The Development of Small Molecule Inhibitors for Gaucher Disease Type 31UH2NS092981-01LARSEN, SCOTT DSHAYMAN, JAMES ALANUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$631,122ZNS1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-14-293: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UH2/UH3) | ScienceDex | ConductScience